Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Clearone (CLRO) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Clearone (CLRO) over the last 16 years, with Q3 2025 value amounting to $663000.0.

  • Clearone's Cash & Equivalents fell 6065.28% to $663000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $663000.0, marking a year-over-year decrease of 6065.28%. This contributed to the annual value of $1.4 million for FY2024, which is 9205.49% down from last year.
  • According to the latest figures from Q3 2025, Clearone's Cash & Equivalents is $663000.0, which was down 6065.28% from $1.7 million recorded in Q2 2025.
  • Clearone's 5-year Cash & Equivalents high stood at $59.0 million for Q1 2023, and its period low was $663000.0 during Q3 2025.
  • Over the past 5 years, Clearone's median Cash & Equivalents value was $1.9 million (recorded in 2021), while the average stood at $8.4 million.
  • In the last 5 years, Clearone's Cash & Equivalents soared by 404950.77% in 2023 and then tumbled by 9205.49% in 2024.
  • Clearone's Cash & Equivalents (Quarter) stood at $1.1 million in 2021, then dropped by 8.12% to $984000.0 in 2022, then surged by 1712.5% to $17.8 million in 2023, then plummeted by 92.05% to $1.4 million in 2024, then plummeted by 53.21% to $663000.0 in 2025.
  • Its Cash & Equivalents stands at $663000.0 for Q3 2025, versus $1.7 million for Q2 2025 and $1.4 million for Q4 2024.